These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 23706948)

  • 1. Incidence and progression of geographic atrophy: observations from a population-based cohort.
    Joachim N; Mitchell P; Kifley A; Rochtchina E; Hong T; Wang JJ
    Ophthalmology; 2013 Oct; 120(10):2042-50. PubMed ID: 23706948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons.
    Wang JJ; Fong CS; Rochtchina E; Cugati S; de Loryn T; Kaushik S; Tan JS; Arnold J; Smith W; Mitchell P
    Ophthalmology; 2012 Nov; 119(11):2298-303. PubMed ID: 22959104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort.
    Joachim N; Mitchell P; Rochtchina E; Tan AG; Wang JJ
    Ophthalmology; 2014 Apr; 121(4):917-25. PubMed ID: 24332537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
    Tan JS; Mitchell P; Smith W; Wang JJ
    Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Progression, and Associated Risk Factors of Medium Drusen in Age-Related Macular Degeneration: Findings From the 15-Year Follow-up of an Australian Cohort.
    Joachim ND; Mitchell P; Kifley A; Wang JJ
    JAMA Ophthalmol; 2015 Jun; 133(6):698-705. PubMed ID: 25838066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort.
    Wang JJ; Foran S; Smith W; Mitchell P
    Arch Ophthalmol; 2003 May; 121(5):658-63. PubMed ID: 12742843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
    Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
    Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
    JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal vessel signs and 10-year incident age-related maculopathy: the Blue Mountains Eye Study.
    Liew G; Kaushik S; Rochtchina E; Tan AG; Mitchell P; Wang JJ
    Ophthalmology; 2006 Sep; 113(9):1481-7. PubMed ID: 16828507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.
    Wang JJ; Rochtchina E; Lee AJ; Chia EM; Smith W; Cumming RG; Mitchell P
    Ophthalmology; 2007 Jan; 114(1):92-8. PubMed ID: 17198852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
    Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
    Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reticular Pseudodrusen and Their Association with Age-Related Macular Degeneration: The Melbourne Collaborative Cohort Study.
    Finger RP; Chong E; McGuinness MB; Robman LD; Aung KZ; Giles G; Baird PN; Guymer RH
    Ophthalmology; 2016 Mar; 123(3):599-608. PubMed ID: 26681391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.
    Joachim N; Mitchell P; Burlutsky G; Kifley A; Wang JJ
    Ophthalmology; 2015 Dec; 122(12):2482-9. PubMed ID: 26383995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study.
    Cugati S; Mitchell P; Rochtchina E; Tan AG; Smith W; Wang JJ
    Ophthalmology; 2006 Nov; 113(11):2020-5. PubMed ID: 16935334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
    Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reticular Pseudodrusen Status, ARMS2/HTRA1 Genotype, and Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report 32.
    Agrón E; Domalpally A; Cukras CA; Clemons TE; Chen Q; Swaroop A; Lu Z; Chew EY; Keenan TDL;
    Ophthalmology; 2023 May; 130(5):488-500. PubMed ID: 36481221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
    Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
    Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
    Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
    Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.